Literature DB >> 2927986

Retinopathy of prematurity: a new epidemic?

D L Gibson1, S B Sheps, M T Schechter, S Wiggins, A Q McCormick.   

Abstract

This study provides the first empiric evidence for the existence of a new epidemic of retinopathy of prematurity-induced blindness. Data from a population-based register of handicapping conditions in the Canadian province of British Columbia, and a birth weight-specific census of live-born infants in British Columbia, were used to determine annual, population-level incidences of retinopathy of prematurity-induced blindness during 1952 to 1983. Changes in incidence since the end of the original epidemic (1954) were determined by subdividing the 29-year period (1955 to 1983) into two intervals (1955 to 1964 and 1965 to 1983). Standardized incidence ratio analyses revealed a marginally significant increase in the overall incidence of retinopathy of prematurity-induced blindness in the later as compared with the earlier period. Infants weighing 750 to 999 g at birth had a significantly increased standardized incidence ratio of 3.07 (95% confidence interval 1.26, 11.06). No increases in risk were observed in heavier or lighter weight infants. Because ascertainment and diagnostic changes do not explain the weight-specific increases in incidence, these results provide the first population-level evidence for a new epidemic.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2927986

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  15 in total

1.  Reduced incidence of retinopathy of prematurity.

Authors:  E Rowlands; A C Ionides; S Chinn; H Mackinnon; C C Davey
Journal:  Br J Ophthalmol       Date:  2001-08       Impact factor: 4.638

Review 2.  Retinopathy of prematurity: recent advances in our understanding.

Authors:  C M Wheatley; J L Dickinson; D A Mackey; J E Craig; M M Sale
Journal:  Br J Ophthalmol       Date:  2002-06       Impact factor: 4.638

Review 3.  Retinopathy of prematurity: recent advances in our understanding.

Authors:  C M Wheatley; J L Dickinson; D A Mackey; J E Craig; M M Sale
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2002-09       Impact factor: 5.747

Review 4.  Screening for retinopathy of prematurity.

Authors:  A R Fielder; M I Levene
Journal:  Arch Dis Child       Date:  1992-07       Impact factor: 3.791

5.  Three year visual outcome for treated stage 3 retinopathy of prematurity: cryotherapy versus laser.

Authors:  I A Pearce; F C Pennie; L M Gannon; A M Weindling; D I Clark
Journal:  Br J Ophthalmol       Date:  1998-11       Impact factor: 4.638

Review 6.  Retinopathy of prematurity: understanding ischemic retinal vasculopathies at an extreme of life.

Authors:  Przemyslaw Sapieha; Jean-Sebastien Joyal; José Carlos Rivera; Elsa Kermorvant-Duchemin; Florian Sennlaub; Pierre Hardy; Pierre Lachapelle; Sylvain Chemtob
Journal:  J Clin Invest       Date:  2010-09-01       Impact factor: 14.808

7.  Dopamine use is an indicator for the development of threshold retinopathy of prematurity.

Authors:  M B Mizoguchi; T G Chu; F M Murphy; N Willits; L S Morse
Journal:  Br J Ophthalmol       Date:  1999-04       Impact factor: 4.638

8.  Retinopathy of prematurity: A systematic review of the literature.

Authors: 
Journal:  Paediatr Child Health       Date:  1998-05       Impact factor: 2.253

9.  Follow-up study on premature infants with and without retinopathy of prematurity.

Authors:  R Robinson; M O'Keefe
Journal:  Br J Ophthalmol       Date:  1993-02       Impact factor: 4.638

Review 10.  The development of the rat model of retinopathy of prematurity.

Authors:  Joshua M Barnett; Susan E Yanni; John S Penn
Journal:  Doc Ophthalmol       Date:  2009-07-29       Impact factor: 2.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.